Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”) a Carlsbad, California-based company that markets a minimally invasive neurostimulation implant for the management of chronic intractable ...
Pendergrast is an anesthesiology resident physician at the University of Michigan. The 1 in 5 Americans suffering from chronic pain may soon lose access to evidence-based interventions that have ...
The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
EDEN PRAIRIE, Minn., March 21, 2025 /PRNewswire/ — To follow up on the completion of its clinical proof-of-concept study, SynerFuse™ and its partner, Velentium Medical, today announced plans to scale ...
Please provide your email address to receive an email when new articles are posted on . Multiple Medicare Administrative Contractors have proposed to restrict coverage for peripheral nerve block ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. After Nick Ventimiglia was diagnosed with diabetes at age 40, he began to experience increasing pain and numbness in his upper ...
POMPANO BEACH, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC provided an update on the Medicare Physician Fee Schedule Proposed Rule published by the Centers for Medicare & Medicaid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback